Cargando…

Prevalence and microbiological and genetic characteristics of multidrug-resistant Pseudomonas aeruginosa over three years in Qatar

OBJECTIVES: Antimicrobial resistance (AMR) is a global priority with significant clinical and economic consequences. Multidrug-resistant (MDR) Pseudomonas aeruginosa is one of the major pathogens associated with significant morbidity and mortality. In healthcare settings, the evaluation of prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sid Ahmed, Mazen A., Abdel Hadi, Hamad, Abu Jarir, Sulieman, Ahmad Khan, Faisal, Arbab, Mohammed A., Hamid, Jemal M., Alyazidi, Mohammed A., Al-Maslamani, Muna A., Skariah, Sini, Sultan, Ali A., Al Khal, Abdul Latif, Söderquist, Bo, Ibrahim, Emad Bashir, Jass, Jana, Ziglam, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726487/ https://www.ncbi.nlm.nih.gov/pubmed/36483382 http://dx.doi.org/10.1017/ash.2022.226

Ejemplares similares

Impact of an antimicrobial stewardship programme on antimicrobial utilization and the prevalence of MDR Pseudomonas aeruginosa in an acute care hospital in Qatar
por: Sid Ahmed, Mazen A, et al.
Publicado: (2020)

Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar
por: Sid Ahmed, Mazen A., et al.
Publicado: (2021)

Evaluation of in Vitro Activity of Ceftazidime/Avibactam and Ceftolozane/Tazobactam against ESBL-producing Enterobacterales Isolated from Intensive Care Units from Qatar
por: Ahmed, Mazen A. Sid, et al.
Publicado: (2022)

Association of bla(VIM-2), bla(PDC-35), bla(OXA-10,) bla(OXA-488) and bla(VEB-9) β-Lactamase Genes with Resistance to Ceftazidime–Avibactam and Ceftolozane–Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa
por: Sid Ahmed, Mazen A., et al.
Publicado: (2022)

1725. National Surveillance of Gram-negative Bacteria in Qatar, the Study for Monitoring of Antimicrobial Resistance Trends (SMART): from 2017 to 2019
por: Sid Ahmed, Mazen A, et al.
Publicado: (2022)

β-lactamase-mediated resistance in MDR-Pseudomonas aeruginosa from Qatar
por: Sid Ahmed, Mazen A., et al.
Publicado: (2020)

The epidemiology and microbiological characteristics of infections caused by Gram-negative bacteria in Qatar: national surveillance from the Study for Monitoring of Antimicrobial Resistance Trends (SMART): 2017 to 2019
por: Sid Ahmed, Mazen A, et al.
Publicado: (2023)

Drug-resistant tuberculosis: an experience from Qatar
por: Ali, Maisa, et al.
Publicado: (2020)

Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar
por: Zaqout, Ahmed, et al.
Publicado: (2020)

Emergence of Multidrug- and Pandrug- Resistant Pseudomonas aeruginosa from Five Hospitals in Qatar
por: Sid Ahmed, M.A., et al.
Publicado: (2019)

Clinical and Epidemiological Characteristics of Stenotrophomonas maltophilia Associated Lower Respiratory Tract Infections in Qatar: A Retrospective Study
por: Nair, Arun P, et al.
Publicado: (2022)

First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017–2020
por: Al-Maslamani, Muna, et al.
Publicado: (2022)

Epidemiology of respiratory infections among adults in Qatar (2012-2017)
por: Al-Romaihi, Hamad Eid, et al.
Publicado: (2019)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
por: AbdulWahab, Atqah, et al.
Publicado: (2017)

HIV case reporting and HIV treatment outcomes in Qatar
por: Farag, Elmoubashar, et al.
Publicado: (2023)

Antemortem diagnosis of human rabies: A case report
por: Goravey, Wael, et al.
Publicado: (2020)

Assessing the impact of climate conditions on the distribution of mosquito species in Qatar
por: Tahir, Furqan, et al.
Publicado: (2023)

Recurrent nasopharyngeal rhinosporidiosis: Case report from Qatar and review of the literature
por: Ali, Gawahir M., et al.
Publicado: (2020)

Molecular characteristics of Neisseria meningitidis in Qatar
por: Hamed, Manal Mahmoud, et al.
Publicado: (2021)

800. Drug-Resistant TB: An Experience From Qatar
por: Ali, Maisa, et al.
Publicado: (2018)

Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012–2017)
por: Al-Romaihi, Hamad E., et al.
Publicado: (2020)

163. Infective Endocarditis in Qatar: Risk Factors, Clinical Characteristics, Microbiology, and Outcomes
por: Zaqout, Ahmed, et al.
Publicado: (2019)

Viral Infections of the Central Nervous System in Qatar: Epidemiology, Pathogenesis and Clinical Outcomes
por: Abid, Fatma Ben, et al.
Publicado: (2017)

A 5-year retrospective study of Actinomyces odontolyticus bacteremia in the state of Qatar, case series
por: Ali, Maisa, et al.
Publicado: (2022)

Candida auris Blood stream infection- a descriptive study from Qatar
por: Koleri, Junais, et al.
Publicado: (2023)

Middle East respiratory syndrome coronavirus infection profile in Qatar: An 8-year experience
por: Ben Abid, Fatma, et al.
Publicado: (2021)

739. Middle East Respiratory Syndrome Coronavirus Infection Profile in Qatar: A 7-Year Retrospective Study
por: Elmaki, Nada, et al.
Publicado: (2018)

Coronavirus disease 2019 in solid organ transplant recipients in the setting of proactive screening and contact tracing of Qatar
por: Alattar, Rand A., et al.
Publicado: (2021)

Epidemiology, microbiological and clinical characteristics of Enterococcus species bloodstream infections: A 10-year retrospective cohort study from Qatar
por: Ali, Gawahir A., et al.
Publicado: (2022)

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar
por: Al Soub, Hussam, et al.
Publicado: (2020)

Actinomyces odontolyticus bacteraemia associated with cervical and mediastinal abscesses in an immunocompetent patient: First reported case in Qatar
por: Razok, Almurtada, et al.
Publicado: (2022)

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
por: Butt, Adeel A., et al.
Publicado: (2023)

Evaluation of Progress of an ACGME-International Accredited Residency Program in Qatar
por: Al-Mohammed, Ahmed, et al.
Publicado: (2020)

A new One Health Framework in Qatar for future emerging and re-emerging zoonotic diseases preparedness and response
por: Bansal, Devendra, et al.
Publicado: (2023)

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
por: Benslimane, Fatiha M., et al.
Publicado: (2021)

Qatar's Response to COVID-19 Pandemic
por: Al Khal, Abdullatif, et al.
Publicado: (2020)

Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar
por: Sid Ahmed, Mazen A, et al.
Publicado: (2016)

All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic
por: AlNuaimi, Asma A, et al.
Publicado: (2023)

Epidemiology Profile of Viral Meningitis Infections Among Patients in Qatar (2015–2018)
por: Mathew, Shilu, et al.
Publicado: (2021)

Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in Qatar
por: Zaqout, Ahmed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7io3nkbg461qvehe9gmih0bif2